Lilac, SM's gunna be pretty bored for the next month or so unless of course he kind find another conference at which to "promote" TIS. Maybe he can get the FDA trial underway which he said was going to start before Q1 this calendar year. He might also work up some non-dilutory funding options (and quickly).
